Long-term remission of refractory stiff-man syndrome after treatment with intravenous immunoglobulin.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10593352.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The stiff-man syndrome is a rare neuromuscular disorder characterized by progressive rigidity, stiffness, and intermittent spasm of axial and extremity muscles. Its etiology is unknown. Different therapeutic regimens have been used with variable success. We present a case of refractory stiff-man syndrome, in which the symptoms were successfully controlled by the administration of intravenous immunoglobulin (IVIg). This case gives evidence that IVIg can be a safe and an efficient treatment of refractory stiff-man syndrome. The exact indication for and the cost-effectiveness of IVIg in the treatment of this rare entity remain to be determined.
Medical subject headings
- Glutamate Decarboxylase
- Immunoglobulins, Intravenous
- Stiff-Person Syndrome